yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33566410-EE0B1E56-0D1D-44B9-ABAA-19C1EF14C62C
Q33566410-EE0B1E56-0D1D-44B9-ABAA-19C1EF14C62C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33566410-EE0B1E56-0D1D-44B9-ABAA-19C1EF14C62C
Targeted Lung Cancer Treatments and Eye Metastasis
P2860
Q33566410-EE0B1E56-0D1D-44B9-ABAA-19C1EF14C62C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33566410-EE0B1E56-0D1D-44B9-ABAA-19C1EF14C62C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4d63b3728398e8de649f3c5a400c934fb1fe48b
P2860
Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer